Join us in Nanjing for CBioPC2026 – Shaping the future of biopharma
Under the theme “High-Quality Development of the Biopharmaceutical Industry,” CBioPC is jointly organized by the China Association for Vaccines (CAV), the Biological Products Branch of the Chinese Preventive Medicine Association, and the Vaccine Professional Committee of the China Medicinal Biotechnology Association. The conference focuses on vaccines, recombinant therapeutic biological products, cell & gene therapy, and blood products, covering the entire industry chain from R&D, production, clinical trials, engineering, supply chain to international cooperation. Bringing together cutting-edge technologies and innovations from domestic and international sources, CBioPC serves as a comprehensive platform for academic exchange, resource matching, market expansion, and brand promotion.
Hedinger｜European Imported Injectable-Grade Pharmaceutical Excipients
- Synthetic glycerin, m-cresol, propylene glycol, glacial acetic acid, dichloroacetic acid, and various other key excipients
- Strictly comply with GMP regulations, meeting and in some cases exceeding the standards of Chinese, US, and European Pharmacopoeias
- Stringent impurity control with low microbial/endotoxin levels; certain products undergo additional dedicated testing for aldehyde and ketone impurities
- Ceramic and glass beads specifically developed for various process scenarios in the pharmaceutical industry
- RTS (Ready-to-sterilize) pre-sterilized grade available, simplifying aseptic handling
- Compliant with ISO 9001 certification and MDF (supported by FDA); independent CoA and analysis reports provided
If you would like to learn more about our products, please feel free to contact us. We also sincerely invite you to visit us at CBioPC 2026 for face-to-face discussions, and to explore new technologies, new trends, and new collaborations in the biopharmaceutical field.
